The American College of Rheumatology (ACR) issued guidelines in 2012 for management of gout, including chronic tophaceous gouty arthropathy (CTGA).
Parameters:
(1) number of joints affected
(2) drainage
(3) risk of infection
(4) growth
(5) presence of severe chronic inflammation related to tophi
(6) presence of aggressive mass and/or connective tissue destructive effects
|
Parameter |
Finding |
Points |
|
drainage |
absent |
0 |
|
|
present |
1 |
|
risk of infection |
low |
0 |
|
|
high |
1 |
|
growth |
none or slow |
0 |
|
|
rapid |
1 |
|
severe chronic inflammation |
absent |
0 |
|
|
present |
1 |
|
aggressive mass or connective tissue destruction |
absent |
1 |
|
|
present |
0 |
number of clinical features =
= SUM(points for all 5 clinical features)
|
Number of Joints Affected |
Number of Clinical Features |
Severity of CTGA |
|
1 |
0 |
mild |
|
2 to 4 |
0 |
moderate |
|
>= 5 |
NA |
severe |
|
>=1 |
>=1 |
severe |
Specialty: Surgery, orthopedic
